| Gender Preference | None |
| Age Group | 0 - 99 years |
| Research Start Date | June 23, 2009 |
| Research End Date | June 23, 2019 |
| Principal Investigator | Ayman El-Sheikh, MD |
| Description | Participants in this study have been diagnosed with acute lymphoblastic leukemia (ALL) or a cancer of the immune system tissue. The purpose of this study is test effectiveness of adding a drug called bortezomib to the standard therapy for relapsed ALL. Approximately 6 people will take part in this study conducted by investigators at the University of Iowa. Study involvement will last approximately 15 weeks. |
| Contact Info | Julie de la Garza, 319-356-3749 |
| Keywords | span itemProp='description'>acute lymphoblastic leukemia (ALL) ; bortezomib ; cancer ; el-sheikh ; immune system tissue ; IRB#200904794 ; pediatric ; |